|
Jul 27, 2022
|
Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
|
|
|
Jul 13, 2022
|
Innoviva Sells 15% Economic Stake in Theravance Respiratory Company to Royalty Pharma for approximately $282 million plus full ownership of existing equity investments and the potential for $50 million milestone payment
|
|
|
Jul 11, 2022
|
Innoviva Completes Acquisition of Entasis Therapeutics
|
|
|
Jul 11, 2022
|
Innoviva to Acquire La Jolla Pharmaceutical Company
|
|
|
Jul 08, 2022
|
Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.
|
|
|
May 23, 2022
|
Innoviva to Acquire Entasis Therapeutics
|
|
|
Apr 27, 2022
|
Innoviva Reports First Quarter 2022 Financial Results
|
|
|
Mar 31, 2022
|
Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $45 Million Private Placement with Innoviva
|
|
|
Mar 03, 2022
|
Innoviva, Inc. Prices Upsized Offering of $225 Million of 2.125% Convertible Senior Notes
|
|
|
Mar 02, 2022
|
Innoviva Announces Proposed Offering of $200 Million of Convertible Senior Notes
|
|